Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

BLCO


Fundamental

Company: Bausch + Lomb Corp
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Canada
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -0.86
Insider Own: 89.26%
Shs Outstand: 354.09M
Perf Week: 0.32%
Market Cap: 5.53B
Forward P/E: 20.08
EPS next Y: 0.78
Insider Trans: 0.01%
Shs Float: 38.04M
Perf Month: 4.98%
Enterprise Value: 10.21B
PEG: -
EPS next Q: 0.36
Inst Own: 8.86%
Short Float: 9.16%
Perf Quarter: 7.88%
Income: -305.00M
P/S: 1.11
EPS this Y: -15.96%
Inst Trans: 0.05%
Short Ratio: 6.65
Perf Half Y: 32.65%
Sales: 4.98B
P/B: 0.86
EPS next Y Percentage: 46.77%
ROA: -2.23%
Short Interest: 3.49M
Perf YTD: -13.62%
Book/sh: 18.16
P/C: 16.64
EPS next 5Y: 16.68%
ROE: -4.69%
52W High: 20.71 -24.67%
Perf Year: -20.16%
Cash/sh: 0.94
P/FCF: -
EPS past 3/5Y: - -
ROIC: -2.69%
52W Low: 10.45 49.28%
Perf 3Y: 12.64%
Dividend Est.: -
EV/EBITDA: 17.92
Sales past 3/5Y: 8.36% 4.87%
Gross Margin: 54.02%
Volatility W: 4.91%
Volatility M: 3.70%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 2.05
EPS Y/Y TTM: 17.53%
Oper. Margin: 2.85%
ATR (14): 0.59
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 0.98
Sales Y/Y TTM: 6.23%
Profit Margin: -6.13%
RSI (14): 51.64
Recom: 2.59
Dividend Gr. 3/5Y: - -
Current Ratio: 1.51
EPS Q/Q: -799.12%
SMA20: 0.04%
Beta: 0.61
Target Price: 16.57
Payout: -
Debt/Eq: 0.77
Sales Q/Q: 7.11%
SMA50: 2.53%
Rel Volume: 0.83
Prev Close: 15.69
Employees: 13500
LT Debt/Eq: 0.77
Earnings: Oct 29 BMO
SMA200: 10.41%
Avg Volume: 523.87K
Price: 15.60
IPO: May 06, 2022
Option/Short: Yes / Yes
EPS/Sales Surpr.: 12.85% 0.27%
Trades:
Volume: 434,810
Change: -0.57%

Technical:


Latest News:

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Bausch + Lomb ... very bullish
AMGN BLCO

Summary: Analysts have expressed bullish sentiments on Amgen (AMGN) and Bausch + Lomb Corporation (BLCO) in the Healthcare sector. Wells Fargo analyst maintained a Buy rating on both companies, setting price targets of $320.00 for Amgen and $23.00 for BLCO. The consensus ratings for these stocks suggest potential upsides of 14.1% and 31.5% respectively.

Full article
2024-04-24T20:31:52Z